Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Klapproth

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Alimentary Pharmacology & Therapeutics|January 1, 1996
Major pathways of mucosal immunity and inflammation: cell activation, cytokine production and the role of bacterial factorsS P James, J M Klapproth
Inflammatory Bowel Diseases|August 29, 2000
Dysplastic polyps in chronic colitis: is colectomy needed?J M Klapproth, B D Greenwald
Zeitschrift Fur Gastroenterologie|May 15, 2012
Aspects in the interdisciplinary decision-making for surgical intervention in ulcerative colitis and its complicationsJ Brown, F Meyer, J-M Klapproth
The American Journal of Physiology|November 1, 1996
Products of enteropathogenic E. coli inhibit lymphokine production by gastrointestinal lymphocytesJ M Klapproth, M S Donnenberg, J M Abraham, et al.
Infection and Immunity|June 1, 1995
Products of enteropathogenic Escherichia coli inhibit lymphocyte activation and lymphokine productionJ M Klapproth, M S Donnenberg, J M Abraham, et al.
Infection and Immunity|March 18, 2000
A large toxin from pathogenic Escherichia coli strains that inhibits lymphocyte activationJ M Klapproth, I C Scaletsky, B P McNamara, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Alimentary Pharmacology & Therapeutics|January 1, 1996
Major pathways of mucosal immunity and inflammation: cell activation, cytokine production and the role of bacterial factorsS P James, J M Klapproth
Inflammatory Bowel Diseases|August 29, 2000
Dysplastic polyps in chronic colitis: is colectomy needed?J M Klapproth, B D Greenwald
Zeitschrift Fur Gastroenterologie|May 15, 2012
Aspects in the interdisciplinary decision-making for surgical intervention in ulcerative colitis and its complicationsJ Brown, F Meyer, J-M Klapproth
The American Journal of Physiology|November 1, 1996
Products of enteropathogenic E. coli inhibit lymphokine production by gastrointestinal lymphocytesJ M Klapproth, M S Donnenberg, J M Abraham, et al.
Infection and Immunity|June 1, 1995
Products of enteropathogenic Escherichia coli inhibit lymphocyte activation and lymphokine productionJ M Klapproth, M S Donnenberg, J M Abraham, et al.
Infection and Immunity|March 18, 2000
A large toxin from pathogenic Escherichia coli strains that inhibits lymphocyte activationJ M Klapproth, I C Scaletsky, B P McNamara, et al.
Pageof 1